US PTO grants Apotex's request to re-examine Plavix patent
This article was originally published in Scrip
Executive Summary
The US Patent and Trademark Office (PTO) has granted Apotex's request for re-examination of the patent covering Sanofi-Aventis/Bristol-Myers Squibb's blood thinner Plavix (clopidogrel), as the Canadian firm has taken another tack in trying to have the patent overturned.